Two Sigma Securities’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,485
Closed -$44K 3230
2022
Q2
$44K Buy
+1,485
New +$44.3K ﹤0.01% 1864
2021
Q2
Sell
-1,802
Closed -$49K 1772
2021
Q1
$49K Buy
+1,802
New +$54.7K ﹤0.01% 736
2019
Q3
Sell
-186
Closed -$6K 2547
2019
Q2
$6K Buy
+186
New +$10.9K ﹤0.01% 2021
2019
Q1
Sell
-171
Closed -$10K 2562
2018
Q4
$10K Sell
171
-3
-2% -$250 ﹤0.01% 2018
2018
Q3
$19K Sell
174
-15
-8% -$1.52K ﹤0.01% 2452
2018
Q2
$20K Buy
+189
New +$20.8K ﹤0.01% 2561
2018
Q1
Sell
-141
Closed -$19K 3021
2017
Q4
$19K Buy
+141
New +$20.3K ﹤0.01% 1632
2017
Q1
Sell
-21
Closed -$10K 1162
2016
Q4
$10K Buy
+21
New +$15.7K ﹤0.01% 674

Other funds holding NURO

Two Sigma Securities's NURO Position: Q3 2022 in Review

Two Sigma Securities sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q3 2022, closing a stake of 1,485 shares — an estimated $44K sold.

Two Sigma Securities first reported a position in NURO in Q4 2016 and held it in 8 quarters. The position peaked at $49K in Q1 2021. 16 funds tracked by Wall St. Rank hold NURO as of Q3 2022.

  • Two Sigma Securities reported no remaining NeuroMetrix, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Securities sold 1,485 NeuroMetrix, Inc. Common Stock shares in Q3 2022, an estimated $44K.
  • Two Sigma Securities first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2016 and held it in 8 quarters.
  • Two Sigma Securities's NeuroMetrix, Inc. Common Stock position peaked at $49K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q3 2022.

Based on Two Sigma Securities's 13F filing for Q3 2022, filed 14 Nov 2022.